BlueSky Immunotherapies
Vienna, Austria· Est.
BlueSky Immunotherapies is a biotech company with its own proprietary technology platform for interferon-inducing viral vectors (delNS). Discover more.
Private Company
Total funding raised: $15M
About
BlueSky Immunotherapies is a biotech company with its own proprietary technology platform for interferon-inducing viral vectors (delNS). Discover more.
Viral Technology
Funding History
2Total raised:$15M
Series A$12M
Seed$3M